Biomedical (applied/exploratory)

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN268201100001I
Awardee
Awarding agency
Task orders
4 $13,054,645 obligated

Award facts

Combined order value
$13,054,645 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 92% used
$14,202,948.00
Maximum order
$14,202,948.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

This Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization. The contract, valued at up to $14,202,948, supports the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Laboratory program. Under this single-award IDC, Vitalant's Vitalant Research Institute (VRI) division provides a range of services, including supplying blood products, conducting research and analysis, and establishing a repository of blood samples.

Task orders issued under the IDC demonstrate VRI's role in supporting REDS-III initiatives. This includes a $727,897 order for laboratory services, a $1,280,451 order to characterize Zika virus transmission through blood transfusions, and an $8,847,513 order for a broader set of REDS-III activities such as study design, protocol development, genetic/metabolomic analysis, and sample management. VRI has subcontracted with the University of California, San Francisco and the University of Pittsburgh to assist with these efforts, which aim to identify factors impacting red blood cell storage and improve the safety and efficacy of blood transfusions.

Task orders

Transactions

Action Obligated Date
Close Out P00013 $0
Other Administrative Action 12 $0
Change Order 11 · Dbdr reds-III - central laboratory $0
Other Administrative Action 10 $0
Other Administrative Action 9 $0
Other Administrative Action 8 $0
Other Administrative Action 7 $0
Change Order 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 · Recipient epidemiology and donor evaluation study III (reds-III) - central laboratory. $0
Change Order 3 · R & d- medical: biomedical (applied research/exploratory development) $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0
Show all 14

Quick answers

Who was awarded contract HHSN268201100001I?

HHSN268201100001I was awarded to Vitalant by National Heart Lung and Blood Institute (National Institutes of Health) on March 15, 2011.

How much is contract HHSN268201100001I worth?

Orders under HHSN268201100001I have obligated $13,054,645. HHSN268201100001I's own ceiling is $14,202,948. A single order can be worth up to $14,202,948.

How many orders have been placed under contract HHSN268201100001I?

4 orders have been placed under HHSN268201100001I, the latest on September 22, 2017.

Who can order from contract HHSN268201100001I?

HHSN268201100001I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN268201100001I competed?

The extent of competition for HHSN268201100001I was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV